Group One Trading’s Acer Therapeutics Inc ACER Stock Holding History

Group One Trading’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,162	Closed	-$2.61K	–	8454
2023 Q3	$2.61K	Buy	+3,162	New	+$2.6K	﹤0.01%	6957
2023 Q1	–	Sell	-680	Closed	-$1.34K	–	8181
2022 Q4	$1.71K	Sell	680 -7,391	-92%	-$12.7K	﹤0.01%	6701
2022 Q3	$11K	Buy	8,071 +6,300	+356%	+$9.12K	﹤0.01%	6467
2022 Q2	$2K	Buy	+1,771	New	+$3.71K	﹤0.01%	7473
2021 Q4	–	Sell	-1,900	Closed	-$4.41K	–	9034
2021 Q3	$5K	Buy	1,900 +200	+12%	+$508	﹤0.01%	7775
2021 Q2	$5K	Sell	1,700 -700	-29%	-$2.02K	﹤0.01%	7791
2021 Q1	$7K	Buy	+2,400	New	+$8.16K	﹤0.01%	7179

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Group One Trading's ACER Position: Q4 2023 in Review

Group One Trading sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 3,162 shares — an estimated $2.61K sold.

Group One Trading first reported a position in ACER in Q1 2021 and held it in 7 quarters. The position peaked at $11K in Q3 2022. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Group One Trading reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 3,162 Acer Therapeutics Inc shares in Q4 2023, an estimated $2.61K.
Group One Trading first reported a position in Acer Therapeutics Inc in Q1 2021 and held it in 7 quarters.
Group One Trading's Acer Therapeutics Inc position peaked at $11K in Q3 2022.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.